Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9739143 | 0.87 | HTR7 (0.48) | HTR7CA2HPGDALDH1A1MEN1 | |
| SCHEMBL23986033 | 0.86 | LMNA (0.48) | HTR7CA2HPGDALDH1A1POLB | |
| SCHEMBL6933031 | 0.85 | ALDH1A1 (0.52) | HTR7CA2ALDH1A1POLBTMEM97 | |
| SCHEMBL9098184 | 0.85 | ALDH1A1 (0.52) | HTR7CA2ALDH1A1POLBTMEM97 | |
| SCHEMBL2493185 | 0.85 | ALDH1A1 (0.52) | HTR7CA2ALDH1A1POLBTMEM97 | |
| SCHEMBL2140747 | 0.84 | HTR7 (0.46) | HTR7CA2HPGDALDH1A1NPC1 | |
| SCHEMBL19136746 | 0.84 | KMT2A (0.49) | HTR7ALDH1A1POLBTMEM97SIGMAR1 | |
| SCHEMBL15542776 | 0.84 | HTR7 (0.46) | HTR7CA2HPGDALDH1A1POLB | |
| SCHEMBL19321859 | 0.82 | HTR7 (0.56) | HTR7CA2HPGDALDH1A1TMEM97 | |
| SCHEMBL11684157 | 0.82 | HTR7 (0.51) | HTR7CA2ALDH1A1TMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160168315-A1 | MODIFIED OLIGOESTERS AND MANUFACTURE METHODS OF THE OLIGOESTERS | ANHIDRIDOS Y DERIVADOS DE COLOMBIA S.A. ANDERCOL (CO) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168315-A1 | MODIFIED OLIGOESTERS AND MANUFACTURE METHODS OF THE OLIGOESTERS | OSTC, OSGEP, PUF60 | HTR7 3275/4885CA2 3154/4885HPGD 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.